Psilocybin Assisted Therapy companies

Key Psilocybin Assisted Therapy Market Players:

The global psilocybin assisted therapy market is expanding quickly, and competition is heating up in North America, Europe, and the Asia-Pacific. Players are heavily investing in clinical trials, patent creation, and regulatory fast-tracks to offer first-mover benefits. Key players such as Compass Pathways and ATAI Life Sciences lead due to robust pipelines and strategic partnerships. India and Malaysia's emerging players are providing government-sponsored alliances to localize production and reduce costs. Similarly, companies in the U.S. and Canada are expanding clinic networks and improving delivery models. Market differentiation is increasingly influenced by therapeutic focus, AI incorporation, and geographical expansion into mental health underserved areas.

Below is the list of some prominent players operating in the global market:

• COMPASS Pathways plc
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis
• Cybin Inc.
• Mind Medicine (MindMed) Inc.
• ATAI Life Sciences N.V.
• Seelos Therapeutics, Inc.
• Numinus Wellness Inc.
• Field Trip Health & Wellness Ltd.
• Usona Institute
• Beckley Psytech Ltd.
• Eleusis Benefit Corporation
• Gilgamesh Pharmaceuticals
• Psyence Biomedical Inc.
• Enveric Biosciences
• Small Pharma Inc.
• Tryp Therapeutics, Inc.
• Bright Minds Biosciences
• Lobe Sciences Ltd.
• Mydecine Innovations Group
• Braxia Scientific Corp.
• Wesana Health Inc.